Cart
sales@molnova.com
Clebopride malate
CAS No. 57645-91-7
Clebopride malate( —— )
Catalog No. M20810 CAS No. 57645-91-7
Clebopride malate is a dopamine antagonist drug?Used to treat functional gastrointestinal disorders such as nausea or vomiting.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 42 | Get Quote |
|
| 10MG | 60 | Get Quote |
|
| 25MG | 95 | Get Quote |
|
| 50MG | 132 | Get Quote |
|
| 100MG | 222 | Get Quote |
|
| 200MG | 331 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameClebopride malate
-
NoteResearch use only, not for human use.
-
Brief DescriptionClebopride malate is a dopamine antagonist drug?Used to treat functional gastrointestinal disorders such as nausea or vomiting.
-
DescriptionClebopride malate is a dopamine antagonist drug?Used to treat functional gastrointestinal disorders such as nausea or vomiting.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetDopamine Receptor
-
RecptorDopamine
-
Research AreaMetabolic Disease
-
IndicationGastroesophageal reflux and functional dyspepsia
Chemical Information
-
CAS Number57645-91-7
-
Formula Weight507.96
-
Molecular FormulaC24H30ClN3O7
-
Purity>98% (HPLC)
-
SolubilityDMSO:34 mg/mL (66.93 mM)
-
SMILESCOc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1.O=C(O)CC(O)C(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bleiberg H Piccart M Lips S et al. A phase I trial of a new antiemetic drug--clebopride malate--in cisplatin-treated patients[J]. Annals of Oncology Official Journal of the European Society for Medical Oncology 1992 3(2):141.
molnova catalog
related products
-
Pridopidine
Pridopidine (ACR16, FR-310826, ASP-2314, Huntexil) is a specific dopamine stabilizer without no partial agonism.
-
4,7-DIHYDROXYCOUMARI...
4, 7-DIHYDROXYCOUMARIN is a bioactive natural compound.
-
UCM-1306
UCM-1306 is a potent and orally active allosteric modulator (PAM) of the human dopamine D1 receptor. It increases the maximal effect of endogenous dopamine (DA) in both human and mouse D1 receptors.
